Copyright
©The Author(s) 2019.
World J Hepatol. Jan 27, 2019; 11(1): 50-64
Published online Jan 27, 2019. doi: 10.4254/wjh.v11.i1.50
Published online Jan 27, 2019. doi: 10.4254/wjh.v11.i1.50
Reference | Country | n | Cutoff values | Criteria | Validated in | |
Takada et al[61],2007 | Japan | 125 | DCP: 400 | Kyoto criteria: up to 10 tumors ≤ 5 cm and DCP ≤ 400 | Fujiki et al[63], 2009; Kaido et al[64], 2013 | |
Soejima et al[62], 2007 | Japan | 60 | DCP: 300 | Kyushu criteria: any number of tumors < 5 cm and DCP < 300 | Shirabe et al[65], 2011 | |
Todo et al[66], 2007 | Japan | 551 | AFP:200, DCP: 100 | A-P level: AFP ≤ 200 and DCP ≤ 100 | ||
Chaiteerakij et al[70], 2015 | United States | 127 | AFP:250, DCP: 7.5 | |||
Yang et al[67], 2016 | Korea | 88 (training cohort); 198 (validation cohort) | AFP: 200; DCP: 200 | A-P 200: AFP ≤ 200 or DCP ≤ 200 | ||
Kim et al[68], 2016 | Korea | 461 | AFP: 150; DCP:100 | -- | ||
Lee et al[69], 2016 | Korea | 566 | AFP and DCP; continuous variables | MoRAL score: 11x√ DCP + 2x√AFP |
- Citation: Citores MJ, Lucena JL, de la Fuente S, Cuervas-Mons V. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. World J Hepatol 2019; 11(1): 50-64
- URL: https://www.wjgnet.com/1948-5182/full/v11/i1/50.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i1.50